Chemicals · Founded 1945 · www.hawcoindia.in · BSE 509597 · · ISIN INE722D01015
No Notes Added Yet
Business
Hardcastle & Waud Manufacturing Company Ltd. is an Indian specialty chemicals manufacturer. The company primarily focuses on developing, manufacturing, and marketing a range of industrial lubricants, metalworking fluids, rust preventives, cleaning chemicals, heat treatment chemicals, and various oil additives. Its core business model involves serving industrial clients across sectors such as automotive, engineering, metal processing, textiles, and general manufacturing. The company generates revenue through the sale of these chemical products, often customized or formulated for specific industrial applications.
Revenue Mix
While specific revenue contribution percentages are not consistently published, Hardcastle & Waud's operations can be broadly categorized by product lines, which include:
Industrial Lubricants: Greases, hydraulic oils, gear oils.
Metalworking Fluids: Cutting oils, grinding fluids, quenchants.
Rust Preventives: Protective coatings and oils.
Cleaning Chemicals: Industrial degreasers and cleaners.
Heat Treatment Salts & Quenching Oils.
Oil Additives: Enhancing performance of lubricants and fuels.
The company's revenue is derived from the sales of these specialized chemical products to its industrial customer base.
Industry
Hardcastle & Waud operates within the competitive Indian chemicals sector, specifically in the niche of industrial specialty chemicals and lubricants. The industry is characterized by a mix of large diversified chemical companies (both domestic and international) and specialized players like Hardcastle & Waud. The company positions itself by offering tailored solutions, technical expertise, and a diversified product portfolio for various industrial applications. It competes on product performance, service, and formulation capabilities within its specific product categories.
MOAT
Hardcastle & Waud's competitive advantages are likely derived from:
Formulation Expertise: Specialized knowledge and R&D capabilities in developing performance-critical chemical formulations for industrial processes.
Customer Stickiness/Switching Costs: For industrial clients, changing suppliers for critical process chemicals or lubricants can involve extensive testing, approvals, and potential disruption to production, creating inherent switching costs.
Established Customer Relationships: Long-standing relationships and technical support offered to industrial clients.
Quality and Reliability: Consistent product quality and performance critical for industrial applications.
Growth Drivers
Industrial Growth in India: Expansion of the manufacturing, engineering, and automotive sectors directly translates to increased demand for lubricants, metalworking fluids, and other process chemicals.
Infrastructure Development: Large-scale infrastructure projects fuel demand in ancillary industries that use the company's products.
Technological Advancements: Development of new, higher-performance, or more environmentally friendly chemical formulations driven by industry trends and regulations.
Diversification into New Applications/Geographies: Expanding product lines or targeting new industrial segments and potential export markets.
Emphasis on Specialty Chemicals: The broader shift towards high-value specialty chemicals in the Indian chemical industry.
Risks
Raw Material Price Volatility: Key inputs such as base oils and specific chemical compounds are often derivatives of crude oil or other global commodities, leading to price fluctuations that can impact profitability.
Intense Competition: The specialty chemicals and industrial lubricants market is highly competitive with both large domestic and international players.
Economic Downturns: A slowdown in the industrial or manufacturing sectors directly reduces demand for the company's products.
Regulatory Changes: Stricter environmental, health, and safety regulations can increase compliance costs or necessitate costly product reformulations.
Technological Obsolescence: Failure to innovate or adapt to new industrial processes and demands can lead to a loss of market share.
Management & Ownership
Hardcastle & Waud Manufacturing Company Ltd. is an Indian-promoted company. The company's management team typically consists of experienced professionals in the chemical and manufacturing sectors. The ownership structure generally includes a significant stake held by the promoter group, ensuring stable leadership and long-term strategic alignment. Specific details about the current board members and key executives would be available in their annual reports or regulatory filings.
Outlook
Hardcastle & Waud operates in a segment crucial to industrial activity. The company's outlook is tied to India's manufacturing growth story and the sustained demand for specialized industrial chemicals. The bull case rests on continued industrialization, infrastructure development, and the company's ability to innovate and maintain strong customer relationships, potentially leading to stable revenue growth and profitability. The bear case involves significant challenges from volatile raw material prices, intense competition requiring continuous R&D investment, and potential slowdowns in key end-user industries. Navigating these factors while expanding its product portfolio and market reach will be key to its future performance.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 2 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 3 |
| Total Expenditure | 0 | 0 | 1 | 0 | 1 | 1 | 2 | 1 | 2 | 1 |
| Operating Profit | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 2 | 2 | 1 |
| Provision for Tax | 0 | -0 | 1 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Profit After Tax | 1 | 1 | -1 | 1 | 0 | 1 | 1 | 1 | 2 | 1 |
| Adjustments | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 1 | 1 | -1 | 1 | 0 | 1 | 1 | 1 | 2 | 1 |
| Adjusted Earnings Per Share | 8 | 16.8 | -8.1 | 9 | 1.3 | 11.3 | 10.4 | 20.8 | 30.1 | 15.7 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 4 | 7 | 8 | 4 | 3 | 4 | 3 | 4 | 4 | 5 | 6 | 10 |
| Other Income | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 6 | 7 | 8 | 4 | 3 | 4 | 3 | 4 | 4 | 6 | 6 | 11 |
| Total Expenditure | 5 | 5 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 3 | 6 |
| Operating Profit | 1 | 2 | 5 | 2 | 1 | 2 | 1 | 2 | 2 | 4 | 4 | 7 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 2 | 5 | 1 | 0 | 1 | 1 | 2 | 1 | 3 | 3 | 6 |
| Provision for Tax | -0 | 11 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 |
| Profit After Tax | 1 | -10 | 4 | 1 | 0 | 1 | 0 | 1 | 1 | 3 | 1 | 5 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 1 | -10 | 4 | 1 | 0 | 1 | 0 | 1 | 1 | 3 | 1 | 5 |
| Adjusted Earnings Per Share | 19.2 | -144.1 | 59.4 | 16.1 | 1.8 | 13.3 | 0.1 | 18.7 | 16.1 | 37.9 | 18.9 | 77 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 20% | 14% | 8% | 4% |
| Operating Profit CAGR | 0% | 26% | 15% | 15% |
| PAT CAGR | -67% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 19% | 25% | 25% | 10% |
| ROE Average | 3% | 4% | 3% | 1% |
| ROCE Average | 6% | 5% | 5% | 5% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 46 | 36 | 36 | 37 | 37 | 35 | 35 | 40 | 42 | 44 | 46 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | -10 | 1 | -0 | -0 | -0 | -1 | -1 | 1 | 1 | 1 | 2 |
| Total Current Liabilities | 2 | 3 | 2 | 2 | 3 | 3 | 3 | 2 | 1 | 1 | 1 |
| Total Liabilities | 38 | 39 | 38 | 39 | 39 | 37 | 37 | 44 | 43 | 46 | 49 |
| Fixed Assets | 7 | 7 | 3 | 3 | 4 | 11 | 4 | 5 | 6 | 5 | 6 |
| Other Non-Current Assets | 11 | 30 | 34 | 35 | 35 | 23 | 29 | 26 | 25 | 36 | 39 |
| Total Current Assets | 20 | 2 | 1 | 1 | 1 | 2 | 4 | 13 | 12 | 5 | 3 |
| Total Assets | 38 | 39 | 38 | 39 | 39 | 37 | 37 | 44 | 43 | 46 | 49 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Cash Flow from Operating Activities | 17 | 1 | -2 | -1 | 1 | 0 | 1 | 3 | -3 | 3 | 1 |
| Cash Flow from Investing Activities | -17 | -1 | 2 | 1 | -1 | -0 | -1 | -3 | 3 | -2 | -2 |
| Cash Flow from Financing Activities | -0 | -0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 |
| Net Cash Inflow / Outflow | 0 | -0 | -0 | -0 | 0 | -0 | 0 | 0 | 0 | 2 | -2 |
| Closing Cash & Cash Equivalent | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 19.18 | -144.14 | 59.4 | 16.06 | 1.76 | 13.26 | 0.14 | 18.72 | 16.13 | 37.94 | 18.94 |
| CEPS(Rs) | 23.92 | -139.28 | 64.67 | 21.85 | 7.32 | 19.22 | 7.11 | 27.38 | 25.64 | 47.84 | 29.58 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 670.23 | 526.08 | 524.44 | 541.2 | 541.7 | 516.53 | 513.71 | 591.84 | 614.63 | 654.53 | 669.95 |
| Core EBITDA Margin(%) | -23.7 | 28.26 | 63.74 | 37.24 | 12.75 | 41.94 | 28.25 | 53.64 | 45.11 | 60.16 | 52.01 |
| EBIT Margin(%) | 30.78 | 23.61 | 61.31 | 30.92 | 6.6 | 35.14 | 17.67 | 44.39 | 33.39 | 55.77 | 47.25 |
| Pre Tax Margin(%) | 30.73 | 23.59 | 61.31 | 30.92 | 6.49 | 35.13 | 17.65 | 44.39 | 33.39 | 55.77 | 47.25 |
| PAT Margin (%) | 35.61 | -139.21 | 49.12 | 25.89 | 4.15 | 25.6 | 0.29 | 30.57 | 28.04 | 47.64 | 21.85 |
| Cash Profit Margin (%) | 44.43 | -134.51 | 53.48 | 35.23 | 17.23 | 37.09 | 15.15 | 44.71 | 44.57 | 60.06 | 34.12 |
| ROA(%) | 3.45 | -25.3 | 10.45 | 2.84 | 0.31 | 2.37 | 0.03 | 3.17 | 2.52 | 5.78 | 2.72 |
| ROE(%) | 2.9 | -24.1 | 11.31 | 3.01 | 0.33 | 2.51 | 0.03 | 3.39 | 2.67 | 5.98 | 2.86 |
| ROCE(%) | 2.51 | 4.09 | 14.11 | 3.6 | 0.52 | 3.43 | 1.61 | 4.92 | 3.18 | 7 | 6.18 |
| Receivable days | 892.78 | 21.85 | 16.98 | 30 | 44.66 | 32.31 | 51.25 | 38.81 | 16.84 | 0 | 38.01 |
| Inventory Days | 0.55 | 0.3 | 0 | 1.07 | 2.64 | 15.21 | 0 | 0 | 0 | 0 | 0 |
| Payable days | 40.76 | 48.2 | 46.91 | 0 | 10.41 | 27.38 | 37.45 | 73.93 | 80.23 | 46.51 | 103.72 |
| PER(x) | 21.54 | 0 | 4.99 | 21.17 | 153.04 | 11.16 | 1286.93 | 13.89 | 21.1 | 16.34 | 34.33 |
| Price/Book(x) | 0.62 | 0.59 | 0.56 | 0.63 | 0.5 | 0.29 | 0.34 | 0.44 | 0.55 | 0.95 | 0.97 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 7.5 | 2.96 | 2.41 | 5.4 | 6.32 | 2.84 | 3.67 | 4.17 | 5.8 | 7.42 | 7.45 |
| EV/Core EBITDA(x) | 18.95 | 10.46 | 3.67 | 13.42 | 32.14 | 6.08 | 11.29 | 7.13 | 11.62 | 10.87 | 12.52 |
| Net Sales Growth(%) | 16.34 | 92.3 | 16.79 | -48.71 | -31.51 | 21.95 | -9.35 | 30.4 | -6.05 | 38.47 | 8.81 |
| EBIT Growth(%) | 368.22 | 47.5 | 203.29 | -74.13 | -85.39 | 549.67 | -54.41 | 227.53 | -29.33 | 131.27 | -7.82 |
| PAT Growth(%) | 730.46 | -851.66 | 141.21 | -72.96 | -89.02 | 652.09 | -98.98 | 0 | -13.82 | 135.25 | -50.09 |
| EPS Growth(%) | 730.46 | -851.66 | 141.21 | -72.96 | -89.02 | 652.1 | -98.98 | 0 | -13.82 | 135.25 | -50.09 |
| Debt/Equity(x) | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio(x) | 8.22 | 0.76 | 0.39 | 0.53 | 0.28 | 0.91 | 1.58 | 5.25 | 18.22 | 6.35 | 2.41 |
| Quick Ratio(x) | 8.22 | 0.76 | 0.39 | 0.52 | 0.27 | 0.81 | 1.58 | 5.25 | 18.22 | 6.35 | 2.41 |
| Interest Cover(x) | 653.94 | 1374.08 | 0 | 0 | 61.48 | 2509.1 | 895.82 | 0 | 0 | 0 | 0 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 73.61 | 73.61 | 73.61 | 73.61 | 73.61 | 73.61 | 73.61 | 73.61 | 73.61 | 73.61 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
| Public | 26.3 | 26.3 | 26.3 | 26.3 | 26.3 | 26.3 | 26.3 | 26.3 | 26.3 | 26.3 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +20% | +14% | +8% | +4% |
| Operating Profit CAGR | 0% | +26% | +15% | +15% |
| PAT CAGR | -67% | 0% | 0% | 0% |
| Share Price CAGR | +19% | +25% | +25% | +10% |
| ROE Average | +3% | +4% | +3% | +1% |
| ROCE Average | +6% | +5% | +5% | +5% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 73.61 | 73.61 | 73.61 | 73.61 | 73.61 | 73.61 | 73.61 | 73.61 | 73.61 | 73.61 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
| Public | 26.3 | 26.3 | 26.3 | 26.3 | 26.3 | 26.3 | 26.3 | 26.3 | 26.3 | 26.3 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.